We did not find any other relationship between PON1-related variables and novel inflammation markers with any other clinical characteristics or comorbidities of COVID-19 positive patients, including type 2 diabetes mellitus, cancer, and chronic kidney disease. Here, PON1 is linked to type 2 diabetes mellitus.